Maladie de Pompe : le salbutamol am\u00e9liorerait l\u2019enzymoth\u00e9rapie substitutive<\/a><\/p>\n\n\n<\/p>","protected":false},"excerpt":{"rendered":"
L’AFM-T\u00e9l\u00e9thon a publi\u00e9 une br\u00e8ve sur les effets du salbutamol dans la maladie de Pompe \u00e0 d\u00e9but tardif. Voir l’article : Maladie de Pompe : le salbutamol am\u00e9liorerait l\u2019enzymoth\u00e9rapie substitutive<\/p>\n","protected":false},"author":7,"featured_media":1106,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[14],"tags":[],"_links":{"self":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/1518"}],"collection":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/comments?post=1518"}],"version-history":[{"count":1,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/1518\/revisions"}],"predecessor-version":[{"id":1519,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/1518\/revisions\/1519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/media\/1106"}],"wp:attachment":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/media?parent=1518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/categories?post=1518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/tags?post=1518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}